Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Siemens Healthineers Widens FY25 EPS Range By €0.15 To Absorb Up To €300M In Tariff Costs
Selective Exposure Allows Diagnostics To Avoid Major Disruptions From Europe-US And US-China Trade Tensions.
Jun 02 2025
•
By
Shubham Singh
Siemens Healthineers CEO Bernhard Montag said the company is well-positioned to adapt, but visibility is required for longer-term investment decisions.
(Shutterstock)
More from Strategy
More from Medtech Insight